126 related articles for article (PubMed ID: 12444102)
41. A novel C-terminal growth hormone receptor (GHR) mutation results in impaired GHR-STAT5 but normal STAT-3 signaling.
Tiulpakov A; Rubtsov P; Dedov I; Peterkova V; Bezlepkina O; Chrousos GP; Hochberg Z
J Clin Endocrinol Metab; 2005 Jan; 90(1):542-7. PubMed ID: 15536163
[TBL] [Abstract][Full Text] [Related]
42. The role of insulin-like growth factors signaling in merlin-deficient human schwannomas.
Ammoun S; Schmid MC; Ristic N; Zhou L; Hilton D; Ercolano E; Carroll C; Hanemann CO
Glia; 2012 Nov; 60(11):1721-33. PubMed ID: 22821509
[TBL] [Abstract][Full Text] [Related]
43. Structure and function of a new STAT-induced STAT inhibitor.
Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T
Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127
[TBL] [Abstract][Full Text] [Related]
44. Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression.
Rong R; Surace EI; Haipek CA; Gutmann DH; Ye K
Oncogene; 2004 Nov; 23(52):8447-54. PubMed ID: 15378014
[TBL] [Abstract][Full Text] [Related]
45. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
46. A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus.
Chen H; Hutt-Fletcher L; Cao L; Hayward SD
J Virol; 2003 Apr; 77(7):4139-48. PubMed ID: 12634372
[TBL] [Abstract][Full Text] [Related]
47. Growth and differentiation of rat hepatocytes: changes in transcription factors HNF-3, HNF-4, STAT-3, and STAT-5.
Runge D; Runge DM; Drenning SD; Bowen WC; Grandis JR; Michalopoulos GK
Biochem Biophys Res Commun; 1998 Sep; 250(3):762-8. PubMed ID: 9784420
[TBL] [Abstract][Full Text] [Related]
48. Immunoblotting analysis of schwannomin/merlin in human schwannomas.
Harwalkar JA; Lee JH; Hughes G; Kinney SE; Golubić M
Am J Otol; 1998 Sep; 19(5):654-9. PubMed ID: 9752976
[TBL] [Abstract][Full Text] [Related]
49. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
[TBL] [Abstract][Full Text] [Related]
50. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.
Le MN; Kohanski RA; Wang LH; Sadowski HB
Mol Endocrinol; 2002 Dec; 16(12):2764-79. PubMed ID: 12456798
[TBL] [Abstract][Full Text] [Related]
51. Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins.
Goutebroze L; Brault E; Muchardt C; Camonis J; Thomas G
Mol Cell Biol; 2000 Mar; 20(5):1699-712. PubMed ID: 10669747
[TBL] [Abstract][Full Text] [Related]
52. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation.
Gebert CA; Park SH; Waxman DJ
Mol Endocrinol; 1997 Apr; 11(4):400-14. PubMed ID: 9092792
[TBL] [Abstract][Full Text] [Related]
53. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
Banes AK; Shaw S; Jenkins J; Redd H; Amiri F; Pollock DM; Marrero MB
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F653-9. PubMed ID: 14678947
[TBL] [Abstract][Full Text] [Related]
54. Expression of schwannomin in lens and Schwann cells.
Claudio JO; Veneziale RW; Menko AS; Rouleau GA
Neuroreport; 1997 May; 8(8):2025-30. PubMed ID: 9223096
[TBL] [Abstract][Full Text] [Related]
55. Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity.
Park SH; Yamashita H; Rui H; Waxman DJ
Mol Endocrinol; 2001 Dec; 15(12):2157-71. PubMed ID: 11731617
[TBL] [Abstract][Full Text] [Related]
56. A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomas.
Gehlhausen JR; Hawley E; Wahle BM; He Y; Edwards D; Rhodes SD; Lajiness JD; Staser K; Chen S; Yang X; Yuan J; Li X; Jiang L; Smith A; Bessler W; Sandusky G; Stemmer-Rachamimov A; Stuhlmiller TJ; Angus SP; Johnson GL; Nalepa G; Yates CW; Wade Clapp D; Park SJ
Hum Mol Genet; 2019 Feb; 28(4):572-583. PubMed ID: 30335132
[TBL] [Abstract][Full Text] [Related]
57. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
[TBL] [Abstract][Full Text] [Related]
58. Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cells.
Spiekermann K; Bagrintseva K; Schwab R; Schmieja K; Hiddemann W
Clin Cancer Res; 2003 Jun; 9(6):2140-50. PubMed ID: 12796379
[TBL] [Abstract][Full Text] [Related]
59. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
[TBL] [Abstract][Full Text] [Related]
60. Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells.
Russell DL; Richards JS
Mol Endocrinol; 1999 Dec; 13(12):2049-64. PubMed ID: 10598581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]